Afficher la couverture 'Type I interferons and SARS-CoV-2: from cells to organisms | Bastard, Paul' en grand format
/5

0 avis

Type I interferons and SARS-CoV-2: from cells to organisms

Archive ouverte

Bastard, Paul | Zhang, Qian | Zhang, Shen-Ying | Jouanguy, Emmanuelle | Casanova, Jean-Laurent

Edité par CCSD ; Elsevier -

International audience. Type I interferons (IFNs) have broad and potent antiviral activity. We review the interplay between type I IFNs and SARS-CoV-2. Human cells infected with SARS-CoV-2 in vitro produce low levels of type I IFNs, and SARS-CoV-2 proteins can inhibit various steps in type I IFN production and response. Exogenous type I IFNs inhibit viral growth in vitro. In various animal species infected in vivo, type I IFN deficiencies underlie higher viral loads and more severe disease than in control animals. The early administration of exogenous type I IFNs improves infection control. In humans, inborn errors of, and auto-antibodies against type I IFNs underlie life-threatening COVID-19 pneumonia. Overall, type I IFNs are essential for host defense against SARS-CoV-2 in individual cells and whole organisms.

Suggestions

Du même auteur

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

Archive ouverte | Asano, Takaki | CCSD

International audience. TLR7 and plasmacytoid dendritic cells are essential for type I IFN–dependent immunity to SARS-CoV-2 in the lungs.

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia

Archive ouverte | Zhang, Qian | CCSD

International audience. Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical COVID-19 pneumonia in unvaccinated adults. The risk of COVID-19 pneumonia in unvaccinated childre...

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

Archive ouverte | Bastard, Paul | CCSD

International audience. We found that 19 (10.4%) of 183 unvaccinated children hospitalized for COVID-19 pneumonia had autoantibodies (auto-Abs) neutralizing type I IFNs (IFN-α2 in 10 patients: IFN-α2 only in three, ...

Chargement des enrichissements...